Showing results (1-10 of 100) with videos related to
Sort By:
Pageof 10
Brain Sciences|February 25, 2022
Advances in Cognitive Remediation Training in Schizophrenia: A ReviewBrianna Fitapelli, Jean-Pierre LindenmayerCurrent Opinion in Psychiatry|February 3, 2021
Noninvasive direct current stimulation for schizophrenia: a reviewJean-Pierre Lindenmayer, Brianna FitapelliInnovations in Clinical Neuroscience|February 8, 2018
Are Shorter Versions of the Positive and Negative Syndrome Scale (PANSS) Doable? A Critical ReviewJean-Pierre LindenmayerDrugs|March 2, 2016
Antipsychotic Management of Schizoaffective Disorder: A ReviewJean-Pierre Lindenmayer, Amandeep KaurSchizophrenia Research|September 21, 2010
Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophreniaJean-Pierre Lindenmayer, Anzalee KhanBMC Psychiatry|November 18, 2011
Use of non-parametric item response theory to develop a shortened version of the Positive and Negative Syndrome Scale (PANSS)Anzalee Khan, Charles Lewis, Jean-Pierre LindenmayerJournal of Child and Adolescent Psychopharmacology|August 26, 2009
Neuroleptic malignant syndrome in children and adolescents on atypical antipsychotic medication: a reviewRachel Neuhut, Jean-Pierre Lindenmayer, Raul SilvaAMIA ... Annual Symposium Proceedings. AMIA Symposium|November 13, 2008
Interface for electronic data capture systems for clinical trials by optimal utilization of available hospital resourcesSashank Kaushik, Anzalee Khan, Saurabh Kaushik, et al.The Journal of Clinical Psychiatry|January 13, 2006
Dosing of quetiapine in schizophrenia: how clinical practice differs from registration studiesLeslie Citrome, Ari Jaffe, Jerome Levine, et al.Clinical Neuropharmacology|March 19, 2013
Long-acting injectable antipsychotics and the development of postinjection delirium/sedation syndrome (PDSS)Vladan Novakovic, Tymaz Adel, Eric Peselow, et al.Pageof 10